禮來(lái)獲批在中國(guó)開(kāi)展Donanemab治療早期癥狀性阿爾茨海默病的臨床試驗(yàn)

array(1) { [406409]=> array(2) { [2]=> array(4) { [0]=> string(6) "中國(guó)" [1]=> string(12) "臨床試驗(yàn)" [2]=> string(18) "阿爾茨海默病" [3]=> string(6) "禮來(lái)" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }